Autolus Therapeutics plc. (AUTL) NASDAQ
$6.38 0.14 (2.24%)
Market Cap: $1.48B
As of 03/28/24 04:00 PM EDT. Market closed.
Autolus Therapeutics plc. (AUTL)
NASDAQ
$6.38
0.14 (2.24%)
Market Cap: $1.48B
As of 03/28/24 04:00 PM EDT. Market closed.
autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. we are building a leading biotechnology company focussed on the development and commercialisation of engineered t-cell therapies for haematological and solid tumours. autolus has the ... read more
autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. we are building a leading biotechnology company focussed on the development and commercialisation of engineered t-cell therapies for haematological and solid tumours. autolus has the ambition to be a leader of a revolution in medicine in which life-threatening diseases are treated by a patient’s own cells. read less
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKSTONE INC. | 20,485,611 | 0.59% | No change | Other |
TFG ASSET MANAGEMENT GP LTD | 8,000,000 | 12.41% | -33.33% | Event Driven, Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,825,532 | 0.05% | New | Other |
BLACKROCK INC. | 1,355,339 | 0.00022% | 76.68% | Other |
UBS OCONNOR LLC | 538,766 | 0.25% | -8.05% | Value |
RENAISSANCE TECHNOLOGIES LLC | 159,600 | 0.00159% | -41.68% | Other |
D. E. SHAW & CO., INC. | 221,489 | 0.00125% | New | Other |
ALPS ADVISORS INC | 128,147 | 0.00248% | Exited | Other |
GEODE CAPITAL MANAGEMENT, LLC | 86,256 | 0.00006% | No change | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View